{
  "ticker": "BBIO",
  "success": true,
  "price": {
    "current": 79.1,
    "currency": "USD",
    "day_high": 79.11,
    "day_low": 77.21,
    "52_week_high": 81.325,
    "52_week_low": 28.325
  },
  "market_cap": {
    "value": 15157694464.0,
    "currency": "USD"
  },
  "shares_outstanding": 191626988.0,
  "volume": {
    "last": 1344647,
    "average_30d": 2861587
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -44.605347,
    "price_to_book": -7.8824115
  },
  "company_info": {
    "name": "BridgeBio Pharma, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 998250000.0,
    "total_liabilities": 2920979000.0,
    "stockholders_equity": -1933070000.0,
    "cash": 642951000.0,
    "marketable_securities": 2991000.0,
    "total_liquidity": 645942000.0,
    "total_debt": 1859737000.0,
    "long_term_debt": 1851016000.0,
    "current_debt": 5294000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:30:16.508000",
    "url": "https://finance.yahoo.com/quote/BBIO",
    "data_hash": "d01243d6a82e55a2"
  }
}